BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv W, Wang Y, Zhao C, Tan Y, Xiong M, Yi Y, He X, Ren Y, Wu Y, Zhang Q. Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer. Front Oncol 2021;11:745719. [PMID: 34722303 DOI: 10.3389/fonc.2021.745719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang YY, Li XW, Li XD, Zhou TT, Chen C, Liu JW, Wang L, Jiang X, Wang L, Liu M, Zhao YG, Li SD. Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy. Front Immunol 2022;13:1055304. [PMID: 36505486 DOI: 10.3389/fimmu.2022.1055304] [Reference Citation Analysis]
2 Cao J, Liang Y, Gu JJ, Huang Y, Wang B. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.991162] [Reference Citation Analysis]
3 Wang Z, Yao J, Dong T, Niu X, Wang F. Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma. Journal of Immunology Research 2022;2022:1-40. [DOI: 10.1155/2022/2756611] [Reference Citation Analysis]
4 Li J, Zhang Y, Li C, Wu H, Feng C, Wang W, Liu X, Zhang Y, Cai Y, Jia Y, Qiao H, Wu F, Zhang S. A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer. Front Genet 2022;13:956246. [DOI: 10.3389/fgene.2022.956246] [Reference Citation Analysis]
5 xiong Y, Kong X, Fang K, Sun G, Tu S, Wei Y, Ouyang Y, Wan R, Xiao W. Establishment of a Novel Signature to Predict Prognosis and Immune Characteristics of Pancreatic Cancer Based on Necroptosis-Related Long Non-Coding RNA.. [DOI: 10.21203/rs.3.rs-2067648/v1] [Reference Citation Analysis]
6 Zhou M, Dong M, Yang X, Gong J, Liao X, Zhang Q, Liu Z. The emerging roles and mechanism of m6a in breast cancer progression. Front Genet 2022;13:983564. [DOI: 10.3389/fgene.2022.983564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Liu Y, Zhu T, Jiang Y, Bu J, Zhu X, Gu X. The Key Role of RNA Modification in Breast Cancer. Front Cell Dev Biol 2022;10:885133. [DOI: 10.3389/fcell.2022.885133] [Reference Citation Analysis]
8 Chen F, Yang J, Fang M, Wu Y, Su D, Sheng Y. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer. J Clin Lab Anal 2022;:e24302. [PMID: 35229919 DOI: 10.1002/jcla.24302] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]